40 Hz Visual Stimulation for Multi-Region Gamma Entrainment in Dementia

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing treatments for dementia, particularly Alzheimer's disease, fail to effectively address circuit-wide disease affecting multiple brain centers responsible for learning and memory, and do not adequately reduce neurodegeneration and neuroinflammation across various brain regions.

Innovation Solution

Non-invasive chronic visual stimulation at frequencies of 30-50 Hz, specifically 40 Hz, is applied to entrain synchronized gamma oscillations in multiple brain regions, including the prefrontal cortex and hippocampus, to enhance gamma coherence and modulate neuronal activity, thereby reducing amyloid plaques, tau hyper-phosphorylation, and neuroinflammation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional treatments for dementia are used, then some symptomatic relief may be achieved, but they fail to effectively address circuit-wide disease affecting multiple brain centers and do not adequately reduce neurodegeneration and neuroinflammation

Engineering Contradiction:
Improveeffectiveness in addressing circuit-wide diseaseVSAvoidability to treat multiple brain regions
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The treatment protocol segments the approach by targeting specific brain regions (visual cortex, hippocampus, prefrontal cortex) with region-specific stimulation parameters, while also addressing multiple regions simultaneously through coordinated multi-site stimulation, thereby achieving circuit-wide disease management

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The stimulation system is designed with multi-functionality to treat multiple brain regions and multiple disease manifestations (neurodegeneration, neuroinflammation, cognitive impairment) through a single integrated platform that can be adjusted for different therapeutic goals

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Reliability

If non-invasive chronic visual stimulation at 40 Hz is applied to entrain synchronized gamma oscillations in multiple brain regions, then gamma coherence and cognitive function are improved, but the treatment requires precise frequency control and prolonged stimulation duration

Engineering Contradiction:
Improvegamma coherence enhancementVSAvoidfrequency control precision requirement
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The system utilizes parameter changes by varying stimulation frequency (centered at 40 Hz gamma band), intensity, and duration to optimize therapeutic effects while managing device complexity through automated control algorithms that adjust parameters based on real-time feedback

Inventive Principle:
Principle #35Parameter changes

3Reliability

If visual stimulation is applied to reduce amyloid plaques and tau hyper-phosphorylation, then neurodegeneration is reduced, but the treatment requires chronic administration over extended periods

Engineering Contradiction:
Improveneurodegeneration reductionVSAvoidtreatment duration
Core Design Contradiction:
ReliabilityVSDuration of action of moving object

Solution Approach 1:

The treatment employs continuous chronic stimulation protocols delivered over extended periods (multiple weeks to months) to accumulate therapeutic effects, ensuring sustained reduction of amyloid plaques and tau hyper-phosphorylation through uninterrupted neural pathway modulation

Inventive Principle:
Principle #20Continuity of useful action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Chronic visual stimulation effectively reduces neurodegeneration, amyloid plaques, and neuroinflammation across multiple brain regions, improving cognitive function and behavioral performance in mouse models of dementia.

Implementation Method 1

Non-invasive chronic visual stimulation at frequencies of 30-50 Hz, specifically 40 Hz, is applied to entrain synchronized gamma oscillations in multiple brain regions

Methodology Applied
Scientific EffectGamma oscillation entrainment: Resonance

Implementation Method 2

Chronic visual stimulation effectively reduces neurodegeneration, amyloid plaques, and neuroinflammation across multiple brain regions

Methodology Applied
Scientific EffectNeuronal oscillation modulation: Resonance

Data Source

PatentUS12515069B2Systems and methods for preventing, mitigating, and/or treating dementia via visual stimulation that binds higher order brain regions, reduces neurodegeneration and neuroinflammation, and improves cognitive function
Publication Date: 2026.01.06 MASSACHUSETTS INST OF TECH
  • US12515069B2 patent drawing
  • US12515069B2 patent drawing
  • US12515069B2 patent drawing

AI summary

Devices, systems, and methods for treating dementia or Alzheimer's disease in a subject in need thereof. In one example, chronic visual stimuli having a frequency of about 30 Hz to about 50 Hz, and more specifically about 40 Hz, are non-invasively delivered to the subject to entrain gamma oscillations in multiple brain regions of the subject, including the prefrontal cortex (PFC) and the hippocampus. The entrained gamma oscillations modulate neuronal activity across multiple brain regions (e.g., facilitate functional binding of neural networks at low gamma frequencies) to induce various neuroprotective effects (e.g., amelioration of amyloid plaques and tau hyper-phosphorylation) and reduce neurodegeneration. Neuronal activity mediated by the chronic visual stimuli reduces an immune response in microglia and ameliorates aberrantly modified genes and proteins involved in membrane trafficking, intracellular transport, synaptic function, neuroinflammation and DNA damage response. Behavior modification including enhanced learning and memory is observed.